Literature DB >> 6588248

Branched-chain amino acid metabolism in chronic renal failure.

A Tizianello, G Deferrari, G Garibotto, C Robaudo, M Lutman, G Passerone, M Bruzzone.   

Abstract

Interorgan exchange of branched-chain amino acids (BCAA) in the postabsorptive state was evaluated in 16 patients with chronic renal failure (CRF) and in 20 subjects with normal renal function, by measuring arterial-venous differences of BCAAs across the leg, brain, hepato-splanchnic (HS) bed, and kidney. In CRF, arterial blood levels of valine are significantly reduced, whereas leucine and isoleucine levels are not different from controls; valine and leucine levels are directly related to GFR. In CRF, a significant decrease in the release of valine by the leg is observed; the leucine release tends to be lower; for both these amino acids, leg release is directly related to their arterial levels. Both ratios of valine and leucine release to total amino acid release by the leg are significantly reduced in CRF. Furthermore, in CRF cerebral uptake and fractional extraction of valine and isoleucine are decreased. In normal subjects, valine and leucine are significantly extracted by the HS bed, whereas in CRF the HS uptake of valine and its fractional extraction fall significantly and leucine uptake is unchanged. The kidney releases significant amounts of leucine both in CRF and in controls. In conclusion, in CRF in the postabsorptive state the exchange of BCAAs, mainly valine, is altered rather early at the major sites of production and utilization, and the flux of these amino acids among the organs is decreased. The primary defect is the decreased output by peripheral tissue, which reduces the supply of BCAAs to the brain and HS bed. Regional metabolic disturbances further impair BCAA utilization.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6588248

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  5 in total

Review 1.  Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view.

Authors:  Francesco Bifari; Enzo Nisoli
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

2.  The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus.

Authors:  Hideki Ikeda
Journal:  J Diabetes Res       Date:  2022-06-13       Impact factor: 4.061

3.  Changes in plasma-concentration ratios of branched-chain amino acids in acute and convalescent phases of bacterial pneumonia.

Authors:  Hideki Ikeda
Journal:  J Clin Biochem Nutr       Date:  2021-11-05       Impact factor: 3.179

4.  Plasma free amino acid profiles and nutrition proteins in chronic renal failure; effect of dialysis treatment.

Authors:  S Troupel; G Le Moel; A Bouten; H Fessi; Z Boukhalfa; G Stamatakis; V Lecon; J Mery; J Agneray; C Jacobs
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

5.  Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children.

Authors:  Lin Sun; Biao Xie; Qiuju Zhang; Yupeng Wang; Xinyu Wang; Bing Gao; Meina Liu; Maoqing Wang
Journal:  Oncotarget       Date:  2017-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.